Genzyme Strengthens Endocrinology Portfolio with Acquisition of Rare Disease Therapy Caprelsa® (vandetanib) from AstraZeneca
Sanofi and its subsidiary Genzyme announced today that it has entered into a definitive agreement with AstraZeneca to ac…
Sanofi and its subsidiary Genzyme announced today that it has entered into a definitive agreement with AstraZeneca to ac…